0.9 % sodium chloride

DRUG4 trials

Sponsors

Corimmun GmbH, Poznan University of Medical Sciences, Sirius Therapeutics Co., Ltd., The Third Xiangya Hospital of Central South University

Conditions

Ankle DiseaseAnkle InjuriesCardiomyopathy, DilatedCoronary Artery Disease (CAD)Foot DiseasesFoot InjuryPain After Abdominal SurgeryPeripheral Arterial Disease

Phase 2

Pilot Study of COR-1 in Heart Failure

CompletedNCT01391507

Corimmun GmbHCardiomyopathy, Dilated

Start: 2011-10-31End: 2013-08-31Updated: 2014-10-17

A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

Not yet recruitingNCT07318155

Sirius Therapeutics Co., Ltd.Coronary Artery Disease (CAD), Peripheral Arterial Disease

Start: 2026-01-31End: 2028-12-31Target: 104Updated: 2026-01-05

Phase 3

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Profile of TRD303 for Postoperative Analgesia After Abdominal Surgery in China.

RecruitingNCT07353307

The Third Xiangya Hospital of Central South UniversityPain After Abdominal Surgery

Start: 2025-12-30End: 2026-12-30Target: 333Updated: 2026-03-27

Phase 4

Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Pediatric Ankle Surgery

CompletedNCT06086418

Poznan University of Medical SciencesAnkle Disease, Ankle Injuries, Foot Diseases +1

Start: 2023-10-17End: 2024-03-30Updated: 2025-01-21

Related Papers

Dexamethasone as a perineural adjuvant to a ropivacaine popliteal sciatic nerve block for pediatric foot surgery: a randomized, double-blind, placebo-controlled trial.

2025-12-059 citations